<DOC>
	<DOCNO>NCT02224768</DOCNO>
	<brief_summary>To evaluate effectiveness YERVOY® educational Risk Minimization ( RM ) tool term awareness tool , utilization , knowledge comprehension Immune Related Adverse Reaction ( irAR ) , appropriate behavior Healthcare Professional ( HCP ) patient</brief_summary>
	<brief_title>YERVOY® Risk Minimization Tool Effectiveness Evaluation Survey</brief_title>
	<detailed_description>A total sample size 160 200 HCPs 160 200 patient</detailed_description>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com HCP experience treatment patient research compound patient receive least one dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>